Predict your next investment

HEALTHCARE | Drug Manufacturing / Generics

See what CB Insights has to offer


Acquired | Acquired

About Kilitch Drugs

Kilitch Drugs is an Indian pharmaceutical company engaged in manufacturing and marketing of generic pharmaceutical formulations in multiple dosage forms, including injectables (liquid and dry), solids, liquids and parenterals. The company has two formulation manufacturing facilities, located in Navi Mumbai and Paonta Sahib, and it markets and distributes a range of ophthalmology products in India and certain overseas markets.In February 2012, Kilitch Drugs was acquired by Akorn. The valuation of Kilitch Drugs was undisclosed. Other terms of the deal were not released.

Kilitch Drugs Headquarter Location

37 Ujagar Industrial Estate Waman Tukaram Patil Marg

400 088,


+91 22 6121 4100

Latest Kilitch Drugs News

Stocks in the news: GAIL, MRF, Majesco, JSW Steel, Glenmark, Titan, Kilitch Drugs

Nov 9, 2018

Stocks in the news: GAIL, MRF, Majesco, JSW Steel, Glenmark, Titan, Kilitch Drugs Glenmark Pharma | JSW Steel | Majesco | Titan Company | Kilitch Drugs | Allahabad Bank | GAIL and MRF are stocks which are in the news today. Results on Friday and Saturday: Results on Sunday: Axiscades Engineering Technologies, Bharat Dynamics related news MRF Q2: Profit declines 12.3 percent to Rs 263 crore versus Rs 300 crore; revenue rises 9.4 percent to Rs 3,928.2 crore from Rs 3,591 crore; EBITDA falls 4.1 percent to Rs 581 crore versus Rs 605.7 crore; margin contracts to 14.8 percent versus 16.9 percent (YoY). Kilitch Drugs Q2: Profit jumps to Rs 4.5 crore versus Rs 2.23 crore; revenue increases to Rs 26.72 crore versus Rs 15 crore YoY. GAIL India: Company has received contract for the purchase of 616 km of line pipe worth Rs 1,100 crore for the Barauni - Guwahati pipeline, putting on fast track project execution of the crucial 729 km feeder line linking North East India with the Pradhan Mantri Urja Ganga pipeline network. Allahabad Bank: Bank has received a communication from the Government of India regarding fresh capital infusion of around Rs 3,054 crore towards contribution of the Central Government in the preferential allotment of equity shares (special securities/bonds) of the bank during the financial year 2018-19. Glenmark Pharma: Company to launch Phase 1 trial in solid tumors for its CD38xCD3 Bispecific Antibody GBR 1342 based on human translational data. JSW Steel: Crude steel production increases 8 percent to 14.47 lakh tonnes in October 2018 against 13.43 lakh tonnes in same month last year. Majesco: PT PFI Mega Life Insurance, the joint venture life insurance company of Prudential Financial Inc and CT Corpora, has selected Majesco Policy for Life & Annuities and Group along with a point of sale and activity management solution specifically used within the Asia Pacific region. HMT: Hitesh Goyal, Deputy Manager (Finance) who was designated as Chief Financial Officer of the company has resigned due to personal reasons and career plans. Bulk Deals Karda Constructions: Marfatia Nishil Surendra purchased 1,00,000 shares of the company at Rs 179.99 per share on the NSE. CL Educate: Ocean Dial Gateway to India Mauritius Limited sold 77,134 shares of the company at Rs 114 per share on the NSE. Gopala Polyplast: Aspire Emerging Fund bought 1,43,626 shares of the company at Rs 60.16 per share on the BSE.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.